Evidence map›Paper›PMID 20519478›Full record

ArticleJournal of clinical microbiology2010

Detection of human parechoviruses from clinical stool samples in Aichi, Japan.

Miyabi Ito, Teruo Yamashita, Hideaki Tsuzuki, Yuka Kabashima, Akiko Hasegawa, Satoko Nagaya, Mariko Kawaguchi, Shinichi Kobayashi, Akira Fujiura, Kenji Sakae and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Article
  3. An outbreak investigation of parechovirus-A3 in a newborn nursery.Infection control and hospital epidemiology · 2024
    Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Miyabi ItoDivision of Virology, Department of Microbiology and Medical Zoology, Aichi Prefectural Institute of Public Health, Nagare 7-6, Tuji-machi, Kita-ku, Nagoya, Aichi 462-8576, Japan. miyabi_itou@prefaichi.lg.jp
Teruo Yamashita
Hideaki Tsuzuki
Yuka Kabashima
Akiko Hasegawa
Satoko Nagaya
Mariko Kawaguchi
Shinichi Kobayashi
Akira Fujiura
Kenji Sakae
Hiroko Minagawa

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Between April 1999 and March 2008, a total of 4,976 stool specimens collected from patients with suspected viral infection through infectious agent surveillance in Aichi, Japan, were tested for the presence of human parechoviruses (HPeVs). We detected HPeVs in 110 samples by either cell culture, reverse transcriptase PCR (RT-PCR), or both. Serotyping either by neutralization test or by nucleotide sequence determination and phylogenetic analysis of the VP1 region and 5' untranslated region (5'UTR) regions revealed that 63 were HPeV type 1 (HPeV-1), followed by 44 HPeV-3 strains, 2 HPeV-4 strains, and 1 HPeV-6 strain. The high nucleotide and amino acid sequence identities of the Japanese HPeV-3 isolates in 2006 to the strains previously reported from Canada and Netherlands confirmed the worldwide prevalence of HPeV-3 infection. Ninety-seven percent of the HPeV-positive patients were younger than 3 years, and 86.2% younger than 12 months. The clinical diagnoses of HPeV-positive patients were gastroenteritis, respiratory illness, febrile illness, exanthema, "hand, foot, and mouth disease," aseptic meningitis, and herpangina. Among 49 HPeV-positive patients with gastroenteritis, 35 were positive with HPeV-1 and 12 with HPeV-3, and out of 25 with respiratory illness, 11 were positive with HPeV-1 and 14 with HPeV-3. HPeV-3 seemed to be an important etiological agent of respiratory infection of children. While HPeV-1 was detected predominantly during fall and winter, the majority of the HPeV-3 cases were detected during summer and fall. A different pattern of clinical manifestations as well as seasonality suggested that there are different mechanisms of pathogenesis between HPeV-1 and HPeV-3 infections.

Indexed as

5' Untranslated RegionsAge FactorsCapsid ProteinsCell Culture TechniquesChild, PreschoolCluster AnalysisFecesFemaleGastroenteritisGenotypeHumansInfantInfant, NewbornJapanMaleMolecular Sequence Data5' Untranslated RegionsCapsid ProteinsRNA, Viral

Identifiers

PMID20519478
PMCPMC2916555
OpenAlexW2138240564

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.